GILD

Gilead Sciences
GILD

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$136.81B
EV
$152.96B
Shares Outstanding
1.25B
Beta
0.31

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$116.00
P/E 2025E
13.79x
P/Revenue 2025E
4.77x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Gilead Sciences, Inc.

gainify
GILD

Gilead Sciences, Inc.

GILD

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Evi...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

O'Day, Daniel P.

Employees

17,600

IPO Date

1992-01-22

Headquarters

333 Lakeside Drive, Foster City, California, 94404, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.